Get more replies from employers
Send a job-specific resume in minutes.
Regeneron Pharmaceuticals, Inc. is seeking a Director of Integrated Data Review to provide strategic leadership for scalable IDR frameworks across clinical programs.
You will establish governance, drive proactive data quality risk management, and ensure inspection-ready data through standardized DRPs and dashboards. You will partner with Biostatistics and QISS to translate RBQM into practical data review approaches, oversee SOPs, and lead training initiatives to ensure broad adoption across
Build our future together: The Director, Integrated Data Review provides strategic leadership for the development, implementation, and continuous improvement of integrated data review processes across clinical programs. In partnership with Biostatistics and cross-functional collaborators, this role establishes scalable frameworks, standards, and oversight models to enable proactive, risk-based identification of data issues and ensure high-quality, inspection-ready clinical data. The position drives consistent execution of Data Review Plans and promotes adoption of integrated data review practices across study teams.
Location: Warren NJ, Armonk NY, and TarryTown NY
Work model/flexibility: on site 4 days a week
Travel percentage: 10%
Define and lead the Integrated Data Review (IDR) strategy, including the implementation of an appropriate operating model, and governance framework across the portfolio. Accountable for consistent execution, oversight, and critical issue of Data Review Plans (DRPs), and proactive identification of data quality risks. Define minimum requirements and develop standardized data review plans methodologies, templates, processes, and guidance to enable consistent and effective execution across study teams. Provide oversight of data review planes execution through established governance processes, KPIs, and quality metrics to ensure consistency, effectiveness, adherence to standards, and continuous improvement across programs. Partner with the Clinical Data Reporting group to develop, implement, and maintain standardized libraries of data review outputs, including visualizations, listings, dashboards, and patient profiles, that support scalable and consistent execution of integrated data review processes across programs. Collaborate with Quantitative Innovation and Statistical Strategy (QISS) team to translate Risk-Based Data Management (RBDM) methodologies into practical data review approaches and study-level requirements. Proactively identify potential risks to data quality, integrity, and delivery timelines and implement mitigation strategies to ensure continuity, compliance, and successful delivery of departmental objectives. Drive continuous improvement and innovation in IDR methodologies and technologies through analysis of metrics, lessons learned, inspection observations, and evolving industry practices. Develop and maintain SOPs, work instructions, templates, and training materials using quality-by-design principles to support integrated data review processes. Lead implementation, change management, and training initiatives to ensure consistent adoption. Drive adoption of IDR methodologies across clinical and external data domains to support proactive issue detection and improved data quality outcomes. Liaise with internal and external collaborators to develop strong relationships and ensure effective cross-functional collaboration and communication with respect to deliverables and throughout drug development process.
Salary Range (annually) $183,100.00 - $305,200.00
Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role:
For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process.
We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.
As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications. For jobs in Canada: this posting is for an existing position.